Background. Chlamydia trachomatis may coinfect with human papillomavirus (HPV) and complicate the cervical pathogenesis. This study aimed to evaluate the prevalence, risk factors, and clinical outcomes of HPV/C. trachomatis coinfection in women from Inner Mongolia, China.
and reduced lifestyle differences. Therefore, this region is ideal for studying diseases influenced by multiple socioeconomic and genetic factors. The aim of this study was to investigate the prevalence, risk factors, and clinical outcomes of HPV/C. trachomatis coinfection in a hospital-based large cohort in this area.
METHODS

Study Design
A study of coinfection between HPV and C. trachomatis was conducted in Inner Mongolia Maternal and Child Care Hospital from January 2015 to September 2017. A population of 2359 women (age range from 19 to 83 years) who visited the department of gynecology of the hospital was invited to participate in this program and submit written consent. A detailed questionnaire was administered to all participants to document their lifestyle pattern and demographic information, including education background, number of lifetime sex partners, residence areas, age, marital status, ethnicity, and profession. Besides detection of pathogens, cervical samples of all participants were also analyzed by thinprep cytologic test (TCT). Participants under medical treatment or with a history of vaccination against HPV were excluded from the study.
Sample Collection
Cervical samples were taken by swab and cytobrush for detection of pathogen DNA and cytological tests, respectively. Swabs were transferred to a tube containing a transport medium (physiological saline; Chaozhou Hybribio Biotechnoloy Corp, China). The interval between sampling and testing was within 3 days (cervical samples can be kept in physiological saline for 2 weeks at 4°C according to the manufacturer's manual).
DNA Extraction
After remove of the swab, cervical cells were collected by centrifugation for 5 minutes with relative centrifugal force 9660g. DNA samples were extracted with alkali lysis using a DNA extraction kit (Chaozhou Hybribio Limited Corp, Chaozhou, China). DNA extracted was quantified by Thermo Scientific NanoDrop 2000 for use in analysis of HPV genotypes and quantification of genomic DNA of the 2 pathogens.
HPV Genotyping
The method of HPV genotyping was described in our previous study [9] . Briefly, a HPV GenoArray test kit (polymerase chain reaction [PCR] plus film chip blot) (Chaozhou Hybribio Limited Corp, Chaozhou, China) was used to detect the 15 high-risk (HR)-HPV genotypes (HPV16, 18, 31, 33, 35, 39, 45 , 51, 52, 53, 56, 58, 59, 66, and 68) and 6 low-risk (LR)-HPV genotypes (HPV6, 11, 42, 43, 44 , and 81) with the MY09/11 primer detection system [10] . The PCR reaction system was 25 µL, comprising 24 µL PCR mix and 1 µL DNA template (50 ng/µL). Thermocycler conditions included an initial denaturation at 95°C for 5 minutes followed by 40 cycles of 95°C for 20 seconds, 55°C for 30 seconds, and 72°C for 30 seconds. The reaction was ended with an elongation of 72°C for 5 minutes. The size of the PCR products was about 441bp [10] .
The 25-µL PCR products were examined with flow-through hybridization and gene chip blotting. The final results were directly visualized on a nylon membrane on which genotype-specific oligonucleotides were immobilized.
qRT-PCR Analysis of Pathogen Genomic DNA
We detected and quantified genomic DNA of the 2 pathogens by a quantitative real-time PCR-based (qRT-PCR) method. A commercial multiplex real-time 12 + 2 HPV test kit (Chaozhou Hybribio Limited Corp, Chaozhou, China) was used for the quantitative detection of HPV DNA, which specifically targets 14 HR-HPV genotypes (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68). Ten-fold serial dilutions (10 −7 copies/mL) of the DNA standard curve were prepared and analyzed. The qRT-PCR test was performed in an Applied Biosystems 7500 real-time PCR system (Applied Biosystems, Foster City, CA), according to the manufacturer's instruction. Briefly, 14 sets of primers and fluorescent probes provided by the manufacturer in a PCR mix regent were used to target the E region of each HR-HPV genotype and detect the amplification products (size: 70-200 bp) [11] . Probes and primers were classified into 4 groups, namely, group 1 for general detection of the 12 non-HPV16/HPV18 HR-HPV genotypes (HPV31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), group 2 for HPV 16, group 3 for HPV 18, and group 4 for a β-globin internal control. Probes were labeled with fluorophores: hexachlorofluorescein for HPV16, carboxy-X-rhodamine for HPV18, 6-carboxy-fluorescein (FAM) for 12 non-HPV16/HPV18 HR-HPV genotypes, and Cy5 for β-globin. The PCR reaction system was 20 µL, comprising 18 µL PCR mix and 2 µL DNA template (50 ng/µL). The reaction conditions for PCR were 95°C for 10 minutes, followed by 45 cycles of 95°C for 10 seconds and 60°C for 60 seconds. The fluorescence signal was detected at 60°C.
A C. trachomatis real-time PCR kit (Shanghai Liferiver Limited Corp, Shanghai, China) was used for detection of C. trachomatis genomic DNA. The PCR reaction system was 40 µL, comprising 36 µL PCR mix and 4 µL DNA templates (50 ng/ µL). Primers and probe, designed according to the sequences of the cryptic plasmid of 5 different C. trachomatis strains (serotypes A, B, D, L1, and L2) and stored in the PCR mix, were provided by the manufacturer [12] . This included a forward primer (5′-CATGAAAACTCGTTCCGAAAT-AGAA-3′), a reverse primer (5′-TCAGAGCTTTACCTAACAACGCATA-3′) (which amplifies a 71-bp DNA segment of C. trachomatis), and a minor-groove binder probe labeled with 5′ FAM (5′-TCGCATGCAAGATATCGA-3′). The PCR test was also performed in the Applied Biosystems 7500 real-time PCR system and the cycling conditions were 2 minutes at 37°C, 2 minutes at 94°C, followed by 40 cycles of 15 seconds at 93°C and 1 minute at 60°C. Signal detection was at 60°C. In order to perform quantification of C. trachomatis genomic DNA, a standard curve was generated with serial 10-fold dilutions of known quantities (10 −7 copy/mL) of a commercial positive control (Bio-Rad Amplichek CT/GC Controls).
Cytology
Slides for liquid-based cytology were prepared and stained according to manufacturer's instructions at the pathology laboratory of the hospital. The results were reported according to the Bethesda System 2001 [13] . The following cytological findings were reported: negative for intraepithelial lesion or malignancy (NILM); atypical glandular cells (AGC); squamous intraepithelial lesions (SIL) of low (LSIL) or high (HSIL) grade; atypical squamous cells (ASC) of undetermined significance (ASC-US) or not possible exclude HSIL (ASC-H); and SCC (squamous cell carcinoma).
Statistics Analysis
Statistical analyses were performed with SPSS version 13.0 (Chicago, IL); t test and Mann-Whitney U test was used to compare pathogen DNA copy numbers between single and coinfection groups. The difference in odds ratios (ORs) for possible risk factors associated with pathogenic infection and corresponding 95% confidence intervals (CIs) were calculated by means of univariate and multivariate logistic regression. Significance was set at P < .05. Age quintiles were computed from the whole population data.
Ethical Consideration
The study was approved and supervised by the local ethics committee of Inner Mongolia Maternal and Child Care Hospital.
RESULTS
Overall Prevalence and Genotype Distribution of HPV Infection
Of the 2359 women who provided cervical cell samples, 2 had mismatched questionnaire information and 12 samples had too many blood cells or excessive cervical secretion that affected DNA extraction, leaving 2345 women with valid testing for pathogen DNA. The percentage of invalid participants for testing was 0.59% (14/2359) . No contamination occurred during testing of the samples.
Analysis by HPV genotyping and HPV real-time PCR gave 839 and 851 positive results, respectively. Thirty-two samples showed discordant results with the 2 different approaches and were further evaluated by sequencing. The sequencing results confirmed that 22 samples were positive (including 8 cases of HPV51/53, 6 cases of HPV16/52, 2 cases of HPV16/33/31, 2 case of HPV16, 2 case of HPV31, 1 case of HPV52, and 1 case of HPV68); the other 10 samples were negative. Thus the number of HPV-positive results was 844 after sequencing confirmation.
Therefore, among the 2345 women, 844 participants (36.0%) were found to be HPV DNA positive, of which 301 showed multiple-genotype (12.8%) infections (Table 1) . Fifteen HR-HPV genotypes and 6 LR-HPV genotypes were detected. HR-HPV infection was confirmed in 824 women. Specifically, HPV16 was the most prevalent genotype (10.4%), followed by HPV58 (6.4%), HPV52 (6.2%), HPV51 (4.2%), and HPV39 (3.3%), while HPV81 (CP8304) was the most common LR-HPV genotype (2.7%).
HPV Genotype Distribution by Cytology Status
Among the 2345 participants, samples from 590 (26.7%) women exhibited the following abnormal cytology: 6 AGC (0.3%), 256 ASC-US (10.9%), 19 ASC-H (0.8%), 170 LSIL (7.2%), 136 HSIL (5.8%), and 3 SCC (0.1%) ( Table 1) .
Of the 844 HPV-DNA-positive women, samples from 431 had ASC-US or higher grade cytology (18.4%, 431/2345);, of which 2 were AGC (0.09%, 2/2345), 140 ASC-US (6.0%), 15 ASC-H (0.6%), 143 LSIL (6.1%), 128 HISL (5.5%), and 3 SCC (0.1%) ( Table 1 ). The HR-HPV genotypes (except for HPV51, HPV59, and HPV68) were more prevalent in participants with HSIL cytological findings than those with NILM. Among the LR-HPV genotypes, HPV42, 44, and 81 were more frequently found among participants with HSIL than those with NILM. HPV16, 53, and 81 were detected in the 3 SCC cases.
The Prevalence of C. trachomatis and HPV Coinfection
Among the overall participants, 335 were C. trachomatis DNApositive (14.3%). Among these, 113 were coinfected with HPV. The DNA load of HPV was significantly higher in the monoinfection group (median = 1.2 × 10 7 copy/mL) compared to the coinfection cases (median = 4.1 × 10 6 copy/mL). In contrast, the DNA load of C. trachomatis was significantly higher in the coinfection group (median = 1.1 × 10 6 copy/mL) than in the monoinfection group (median = 9.2 × 10 5 copy/mL; Figure 1 ).
Age Quintile and HPV Genotype Distribution in Coinfected Patients
In HPV-positive patients, the prevalence of HPV dropped from age quintile 1 (36.2%) to age quintile 3 (30.7%) and then increased progressively to age quintile 5 (42.4%) ( Table 2 and Figure 2A ). In the coinfection group, most participants were in age quintile 1 (10.4%) ( Table 2 and Figure 2B ).
Among the coinfected participants, 14 HR-HPV genotypes (except for HPV35) and 4 LR-HPV genotypes (except for HPV42 and 43) were present. HR-HPV genotypes, including HPV66 (1.5%), HPV52 (1.2%), HPV16 (1.1%), HPV56 (1.0%), and HPV58 (0.9%) were identified in the 113 coinfected cases (Table 3) . HPV11 was the most common LR-HPV genotype (0.5%). Table 4 shows the association between HPV mono-or coinfection with residence areas, ethnicity, education background, profession, marital status, and lifetime number of sex partners. Most indicators, except ethnicity, were significantly associated with HPV-positive results. For coinfection with HPV A, Genomic DNA load of HPV (copy/mL) among women with monoinfection (median = 1.2 × 10 7 copy/mL) and coinfection (median = 4.1 × 10 6 copy/mL). **P < .01, Mann-Whitney test. B, Genomic DNA load of C. trachomatis (copy/mL) among women with monoinfection (median = 1.1 × 10 6 copy/mL) and coinfection (median = 9.2 × 10 5 copy/mL). *P < .05, t test. Median and interquartile range indicated by solid lines in the graph. The 95% confidence interval (CI) was obtained by using binomial distribution analysis model. P value: the HPV prevalence between NILM and abnormal cytological findings was compared using Χ 2 test. Bold type indicates statistically significant values.
Potential Risk Factors
Abbreviations: %, prevalence percentage; AGC, atypical glandular cells; ASC-H, atypical squamous cells not possible exclude HSIL; ASC-US, atypical squamous cells of undetermined significance; HR-HPV, high-risk human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; LR-HPV, low-risk human papillomavirus; LSIL, low-grade squamous intraepithelial lesion; n, number of cases; NILM, negative for intraepithelial lesion or malignancy; OR, odds ratio; SCC, squamous cell carcinoma.
and C. trachomatis, marital status and lifetime sex partners were potential risk factors. Single women (OR = 6.0; 95% CI, 4.044-8.782) or women with >2 sex partners (OR = 1.9; 95% CI, 1.324-2.824) were more likely to be infected with both HPV and C. trachomatis.
Coinfection of C. trachomatis and HPV Increases the Risk of Abnormal
Cytology
Among the 335 participants with C. trachomatis infection, 77 had ASC-US (3.3%, 77/2345), 1 ASC-H (0.04%), 52 LSIL (2.2%), 36 HSIL (1.5%), and 3 SCC (0.1%) ( Table 1) . Among the 113 coinfected participants, 90 had abnormal cytological findings and 36 HSIL (Table 3) . Thus, coinfection has dramatically increased the risk for abnormal cytology (OR = 11.6; 95% CI, 7.29-18.6). Specifically, coinfection with different HR-HPV genotypes, including HPV16, 18, 31, 33, 39, 52, 53, 56, 58, and 66, showed a higher risk for ASC-US or higher grade cytology. Coinfection with HR-HPV genotypes, including HPV16, 18, 31, 39, 52, 58, 66, and 68, showed increased risk for HSIL. Of note, all the 3 SCC cases detected in this study were in the coinfected population. Among the confections with LR-HPV genotypes, HPV11 and HPV81 showed a higher risk for ASC-US or higher grade cytology and no LR-HPV genotypes exhibited increased risk for HSIL.
Furthermore, the rate of LSIL or HSIL in each age quintile with coinfection was clearly higher than those with HPV monoinfection. Of the 3 SCC cases, 2 were identified in age quintile 3 and 1 in age quintile 5 of the coinfection group. 
DISCUSSION
In this study, 2345 women who visited the Department of Gynecology, Inner Mongolian Maternal and Child Care Hospital were recruited for an HPV and C. trachomatis screening program. The prevalence of HPV-DNA was 36.0% in this population, whereas HPV prevalence from other parts of China ranges from 9.03% to 16.8% [14, 15] . Furthermore, we identified 335 participants to be C. trachomatis DNA positive (14.3%) by real-time PCR. The sensitivity and specificity of this method is 95.7% and 100%, respectively [12] .
Among the C. trachomatis infected participants, 113 were coinfected with HPV, and HPV16, HPV58, and HPV52 were the most common genotypes in this population. This finding is similar to that in most regions of China and other areas of East Asian, although there are variations in different region [15] [16] [17] [18] [19] . HPV16 and HPV52 were more common in HSIL cytology.
HPV16 was the most prevalent genotype in normal and abnormal cytological findings. Interestingly, HPV66 represented the genotype most frequently detected in coinfected participants and nearly half of the cases with this genotype developed abnormal cytology. HPV66 was also common in coinfection with LSIL or HSIL. The overall prevalence of HPV66 is usually low in HPV screening of Chinese women [9] . However, it appears more prone to coinfect with C. trachomatis than other genotypes. We found the rate of multiple HPV genotypes in coinfected women was higher than that in those with HPV monoinfection. It has been previously reported that HPV multiple infection dose not increase the risk of acquiring further infection but may impair the local immune system [20] . Interestingly, patients with coinfection had significantly higher load of C. trachomatis DNA compared with monoinfection of C. trachomatis. We speculate that this may be associated with host immune response to the The 95% confidence interval (CI) was obtained by using binomial distribution analysis model.
P value: the HPV prevalence between NILM and abnormal cytological findings was compared using Χ 2 test. Bold type indicated statistically significant values.
infection of 2 pathogens, but further research is required to validate our hypothesis. Risk factors that significantly increased the odds of HPV-C. trachomatis coinfection in Inner Mongolia included marital status and number of lifetime sex partners. We found that married women were less likely to be coinfected as compared to single women. Whereas, women with 2 or more sexual lifetime partners had a higher risk of coinfection as compared to women with 1 sexual partner. We found that sexual contact with many partners increases the odds ratio for HPV monoinfection, which is consistent with previous studies [21] [22] [23] . As C. trachomatis is mainly sexually transmitted, we expect that coinfection is also likely associated with risky sex behaviors. Coinfection is possibly acquired by interactions with multiple hosts who may each be infected with a particular pathogen species. These interactions may change the transmission, clinical progression, and control of infectious diseases [24, 25] . We found that younger age was associated with a higher C. trachomatis infection prevalence, which may be related to more risky sexual behavior. Risk factors, including residence areas, education, and profession, were significantly associated with HPV infection, but were not significantly related to coinfection. Also, unexpectedly, no significant association was observed between ethnicity and risk of coinfection. This is probably due to extensive ethnic miscegenation in the region, or the size of studied population was not large enough.
The association of cervical abnormalities and HPV-C. trachomatis coinfection was in line with previous studies with small cohorts [26, 27] . Coinfection is known to trigger a much stronger inflammatory reaction [28] and C. trachomatis infection is often associated with HPV persistence [29, 30] . Persistent HPV infection in basal keratinocytes of mucosal epithelium requires an altered epithelial environment. C. trachomatis infection may lead to epithelial disruption and therefore may facilitate entry of the virus [31] . Chlamydial infection might also disturb the immune response that is necessary to clear the virus [31] . Furthermore, we found that coinfection of HR-HPV and C. trachomatis exhibited more severe pathogenesis, in particular higher risk of HSIL. Based on the numbers of abnormal cytological findings, C. trachomatis monoinfection was associated with low-grade cervical abnormalities (ASC-US or LSIL), but was less likely to be associated with high-grade cervical lesions (HSIL or SCC). The number of cases with HSIL in the coinfection group was significantly higher than that in the HPV monoinfection group. Among 844 HPV-positive cases 128 (15.2%) had HSIL. Among the 113 participants with coinfection, 36 (31.9%) had HSIL. Importantly, all 3 SCC cases were found in patients with coinfection. Interestingly, the genomic DNA loads of both pathogens were significantly different in mono-versus coinfection, indicating the active interactions of these 2 pathogens. But the exact biological implications of these findings remain to be further explored. Of note, our study has some limitations. Information on the history of women with HPV or C. trachomatis infection prior to enrollment or in the follow-up is lacking. These data could help to better interpret the risk factors for persistent HPV infection. Other STD pathogens, including Neisseria gonorrhoeae and HSV-1 and -2, which may also contribute to the progression of cervical cancer, were not tested in the study.
In summary, we report the rates of HPV and C. trachomatis monoinfection and coinfection were 36.0%, 14.3%, and 4.8%, respectively, in women from Inner Mongolia, China. Factors including marital status and number of lifetime sex partners were significantly associated with coinfection. Importantly, coinfection resulted in more severe cervical pathogenesis and progression to carcinogenesis. These findings bear important implications for future screening and management of patients with HPV and C. trachomatis coinfection.
Notes
